Search

everythinglearnresearchcommunity

for

Search:↓

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

Alopecia areata may protect against graft dysfunction, while asthma may increase its risk.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Iron chelators can effectively reduce hair loss and improve hair growth in autoimmune alopecia.

Type 1 diabetes may cause certain autoimmune diseases in Europeans.

Certain genes may be linked to autoimmune conditions in people with alopecia areata.

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.

NK cells play a role in skin diseases like eczema and psoriasis.

Redefining drug dosages is crucial when repurposing them for new uses.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

More precise, personalized therapies are needed for autoimmune diseases.

Hydrogel microneedles offer a painless, effective way to treat skin disorders.

A specific genetic change is linked to mental disorders, intellectual disability, and possibly autoimmune disease in a family.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Hair loss can indicate various health issues, including serious diseases, hormonal imbalances, and can significantly affect personal life and mental health.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Adalimumab may cause severe hair loss in some patients.

Stress may trigger hair loss by affecting immune protection in hair follicles.

Osteopontin may play a role in alopecia areata, but its levels don't predict treatment success.

Machine learning can help find new ways to treat alopecia areata.

Secondary plant metabolites may offer a safer treatment for alopecia areata.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

Dupilumab may help regrow hair in people with severe alopecia.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

The instruments are valid but don't fully capture the emotional impact on adolescents with alopecia areata.

Janus kinase inhibitors show promise for treating alopecia areata in children.

COVID-19 can increase the risk of hair loss, especially in people over 40.